{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T09:08:24Z","timestamp":1791277704590,"version":"4.1.0"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2011,9,27]],"date-time":"2011-09-27T00:00:00Z","timestamp":1317081600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Rheumatol Int"],"published-print":{"date-parts":[[2012,10]]},"DOI":"10.1007\/s00296-011-2150-1","type":"journal-article","created":{"date-parts":[[2011,9,26]],"date-time":"2011-09-26T07:19:30Z","timestamp":1317021570000},"page":"3143-3148","source":"Crossref","is-referenced-by-count":50,"title":["Bone density in Moroccan women with systemic scleroderma and its relationships with disease-related parameters and vitamin D status"],"prefix":"10.1007","volume":"32","author":[{"given":"Yousra","family":"Ibn Yacoub","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bouchra","family":"Amine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Assia","family":"Laatiris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fahd","family":"Wafki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fatima","family":"Znat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Najia","family":"Hajjaj-Hassouni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2011,9,27]]},"reference":[{"key":"2150_CR1","first-page":"1718","volume":"34","author":"ME Suarez-Almazor","year":"2007","unstructured":"Suarez-Almazor ME, Kallen MA, Roundtree AK, Mayes M (2007) Disease and symptom burden in systemic sclerosis: a patient perspective. J Rheumatol 34:1718\u20131726","journal-title":"J Rheumatol"},{"key":"2150_CR2","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1186\/1471-2458-7-260","volume":"7","author":"F Allali","year":"2007","unstructured":"Allali F, Tahiri L, Senjari A, Abouqal R, Hajjaj-Hassouni N (2007) Erosive arthropathy in systemic sclerosis. BMC Public Health 7:260","journal-title":"BMC Public Health"},{"issue":"4","key":"2150_CR3","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1016\/j.semarthrit.2004.08.006","volume":"34","author":"J Loucks","year":"2005","unstructured":"Loucks J, Pope JE (2005) Osteoporosis in scleroderma. Semin Arthritis Rheum 34(4):678\u2013682","journal-title":"Semin Arthritis Rheum"},{"issue":"5","key":"2150_CR4","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1080\/03009740600704296","volume":"35","author":"RB Souza","year":"2006","unstructured":"Souza RB, Borges CT, Takayama L, Aldrighi JM, Pereira RM (2006) Systemic sclerosis and bone loss: the role of the disease and body composition. Scand J Rheumatol 35(5):384\u2013387","journal-title":"Scand J Rheumatol"},{"issue":"3","key":"2150_CR5","first-page":"313","volume":"22","author":"B Frediani","year":"2004","unstructured":"Frediani B, Baldi F, Falsetti P, Acciai C, Filippou G, Spreafico A, Siagri C, Chellini F, Capperucci C, Filipponi P, Galeazzi M, Marcolongo R (2004) Clinical determinants of bone mass and bone ultrasonometry in patients with systemic sclerosis. Clin Exp Rheumatol 22(3):313\u2013318","journal-title":"Clin Exp Rheumatol"},{"issue":"7","key":"2150_CR6","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/j.autrev.2010.02.011","volume":"9","author":"CF Pelajo","year":"2010","unstructured":"Pelajo CF, Lopez-Benitez JM, Miller LC (2010) Vitamin D and autoimmune rheumatologic disorders. Autoimmun Rev 9(7):507\u2013510","journal-title":"Autoimmun Rev"},{"issue":"14","key":"2150_CR7","doi-asserted-by":"crossref","first-page":"2579","DOI":"10.1096\/fj.01-0433rev","volume":"15","author":"HF Deluca","year":"2001","unstructured":"Deluca HF, Cantorna MT (2001) Vitamin D: its role and uses in immunology. FASEB J 15(14):2579\u20132585","journal-title":"FASEB J"},{"issue":"7","key":"2150_CR8","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1177\/0961203309360807","volume":"19","author":"E Cutillas-Marco","year":"2010","unstructured":"Cutillas-Marco E, Morales-Su\u00e1rez-Varela M, Marquina-Vila A, Grant W (2010) Serum 25-hydroxyvitamin D levels in patients with cutaneous lupus erythematosus in a Mediterranean region. Lupus 19(7):810\u2013814","journal-title":"Lupus"},{"issue":"7\u20138","key":"2150_CR9","first-page":"535","volume":"93","author":"BT Alexandersson","year":"2007","unstructured":"Alexandersson BT, Geirsson AJ, Olafsson I, Franzson L, Sigurdsson G, Gudbjornsson B (2007) Bone mineral density and bone turnover in systemic sclerosis. Laeknabladid 93(7\u20138):535\u2013541","journal-title":"Laeknabladid"},{"issue":"11","key":"2150_CR10","doi-asserted-by":"crossref","first-page":"2201","DOI":"10.3899\/jrheum.071171","volume":"35","author":"Y Braun-Moscovici","year":"2008","unstructured":"Braun-Moscovici Y, Furst DE, Markovits D, Rozin A, Clements PJ, Nahir AM, Balbir-Gurman A (2008) Vitamin D, parathyroid hormone, and acroosteolysis in systemic sclerosis. J Rheumatol 35(11):2201\u20132205","journal-title":"J Rheumatol"},{"key":"2150_CR11","doi-asserted-by":"crossref","unstructured":"Masi AT and the subcommittee for scleroderma criteria of the American Rheumatism Association diagnostic and therapeutic criteria committee. Preliminary criteria for the classification of systemic sclerosis (scleroderma). Arthritis Rheum 1980; 23: 581\u201390","DOI":"10.1002\/art.1780230510"},{"key":"2150_CR12","first-page":"1573","volume":"28","author":"EC LeRoy","year":"2001","unstructured":"LeRoy EC, Medsger TA Jr (2001) Criteria for the classification of early systemic sclerosis. J Rheumatol 28:1573\u20131576","journal-title":"J Rheumatol"},{"key":"2150_CR13","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/s10067-004-0942-3","volume":"24","author":"C Georges","year":"2005","unstructured":"Georges C, Chassany C, Mouthon L, Tiev K, Toledano C, Meyer O et al (2005) Validation of French version of the scleroderma Health Assessment Questionnaire (SSc HAQ). Clin Rheumatol 24:3\u201310","journal-title":"Clin Rheumatol"},{"key":"2150_CR14","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1007\/BF02207673","volume":"14","author":"O Di Munno","year":"1995","unstructured":"Di Munno O, Mazzantini M, Massei P, Ferdeghini M, Petaro N, Latorraca A et al (1995) Reduced bone mass and normal calcium metabolism in systemic sclerosis with and without calcinosis. Clin Rheumatol 14:407\u2013412","journal-title":"Clin Rheumatol"},{"issue":"2","key":"2150_CR15","first-page":"180","volume":"23","author":"PD Sampaio-Barros","year":"2005","unstructured":"Sampaio-Barros PD, Costa-Paiva L, Filardi S, Sachetto Z, Samara AM, Marques-Neto JF (2005) Prognostic factors of low bone mineral density in systemic sclerosis. Clin Exp Rheumatol 23(2):180\u2013184","journal-title":"Clin Exp Rheumatol"},{"issue":"1","key":"2150_CR16","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1590\/S0104-42301997000100010","volume":"43","author":"HC Silva Da","year":"1997","unstructured":"Da Silva HC, Szejnfeld VL, Assis LS, Sato EI (1997) Study of bone density in systemic scleroderma. Rev Assoc Med Bras 43(1):40\u201346","journal-title":"Rev Assoc Med Bras"},{"issue":"1","key":"2150_CR17","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1007\/BF02208027","volume":"10","author":"G Montagna La","year":"1991","unstructured":"La Montagna G, Vatti M, Valentini G, Tirri G (1991) Osteopenia in systemic sclerosis. Evidence of a participating role of earlier menopause. Clin Rheumatol 10(1):18\u201322","journal-title":"Clin Rheumatol"},{"key":"2150_CR18","doi-asserted-by":"crossref","unstructured":"Carbone L, Tylavsky F, Wan J, McKown K, Cheng S (1999) Bone mineral density in scleroderma. Rheumatol (Oxford) 371\u2013372","DOI":"10.1093\/rheumatology\/38.4.371"},{"issue":"6","key":"2150_CR19","first-page":"1073","volume":"35","author":"SY Yuen","year":"2008","unstructured":"Yuen SY, Rochwerg B, Ouimet J, Pope JE (2008) Patients with scleroderma may have increased risk of osteoporosis. A comparison to rheumatoid arthritis and noninflammatory musculoskeletal conditions. J Rheumatol 35(6):1073\u20131078","journal-title":"J Rheumatol"},{"issue":"3","key":"2150_CR20","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1093\/rheumatology\/40.3.310","volume":"40","author":"G La Montagna","year":"2001","unstructured":"La Montagna G, Baruffo A, Pasquali D, Bellastella A, Tirri G, Sinisi AA (2001) Assessment of pituitary gonadotropin release to gonadotropin releasing hormone\/thyroid-stimulating hormone stimulation in women with systemic sclerosis. Rheumatol 40(3):310\u2013314","journal-title":"Rheumatol"},{"issue":"11","key":"2150_CR21","doi-asserted-by":"crossref","first-page":"2206","DOI":"10.3899\/jrheum.080192","volume":"35","author":"A Dovio","year":"2008","unstructured":"Dovio A, Data V, Carignola R, Calzolari G, Vitetta R, Ventura M, Saba L, Severino A, Angeli A (2008) Circulating osteoprotegerin and soluble RANK ligand in systemic sclerosis. J Rheumatol 35(11):2206\u20132213","journal-title":"J Rheumatol"},{"issue":"10","key":"2150_CR22","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1517\/14712598.6.10.1041","volume":"6","author":"EM Lewiecki","year":"2006","unstructured":"Lewiecki EM (2006) RANK ligand inhibition with denosumab for the management of osteoporosis. Expert Opin Biol Ther 6(10):1041\u20131050","journal-title":"Expert Opin Biol Ther"},{"issue":"3","key":"2150_CR23","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1007\/s10067-009-1324-7","volume":"29","author":"J Kim","year":"2010","unstructured":"Kim J, Park SK, Moon KW, Lee EY, Lee YJ, Song YW, Lee EB (2010) The prognostic factors of systemic sclerosis for survival among Koreans. Clin Rheumatol 29(3):297\u2013302","journal-title":"Clin Rheumatol"},{"key":"2150_CR24","doi-asserted-by":"crossref","unstructured":"Caramaschi P, Dalla Gassa A, Ruzzenente O, Volpe A, Ravagnani V, Tinazzi I, Barausse G, Bambara LM, Biasi D (2010) Very low levels of vitamin D in systemic sclerosis patients. Clin Rheumatol [Epub ahead of print]","DOI":"10.1007\/s10067-010-1478-3"},{"issue":"6","key":"2150_CR25","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1016\/j.semarthrit.2008.01.009","volume":"38","author":"F Allali","year":"2009","unstructured":"Allali F, El Aichaoui S, Khazani H, Benyahia B, Saoud B, El Kabbaj S, Bahiri R, Abouqal R, Hajjaj-Hassouni N (2009) High prevalence of hypovitaminosis D in Morocco: relationship to lifestyle, physical performance, bone markers, and bone mineral density. Semin Arthritis Rheum 38(6):444\u2013451","journal-title":"Semin Arthritis Rheum"},{"key":"2150_CR26","doi-asserted-by":"crossref","unstructured":"Belloli L, Ughi N, Marasini B (2010) Vitamin D in systemic sclerosis. Clin Rheumatol","DOI":"10.1007\/s10067-010-1564-6"},{"issue":"9","key":"2150_CR27","doi-asserted-by":"crossref","first-page":"1924","DOI":"10.3899\/jrheum.081287","volume":"36","author":"A Vacca","year":"2009","unstructured":"Vacca A, Cormier C, Piras M, Mathieu A, Kahan A, Allanore Y (2009) Vitamin D deficiency and insufficiency in 2 independent cohorts of patients with systemic sclerosis. J Rheumatol 36(9):1924\u20131929","journal-title":"J Rheumatol"},{"issue":"8","key":"2150_CR28","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1038\/ncprheum0855","volume":"4","author":"L Adorini","year":"2008","unstructured":"Adorini L, Penna G (2008) Control of autoimmune diseases by the vitamin D endocrine system. Nat Clin Pract Rheumatol 4(8):404\u2013412","journal-title":"Nat Clin Pract Rheumatol"},{"issue":"3\u20135","key":"2150_CR29","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1016\/j.jsbmb.2006.12.094","volume":"103","author":"E Etten Van","year":"2007","unstructured":"Van Etten E, Gysemans C, Branisteanu DD, Verstuyf A, Bouillon R, Overbergh L, Mathieu C (2007) Novel insights in the immune function of the vitamin D system: synergism with interferon-beta. J Steroid Biochem Mol Biol 103(3\u20135):546\u2013551","journal-title":"J Steroid Biochem Mol Biol"},{"issue":"10","key":"2150_CR30","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1001\/archderm.1994.01690100074012","volume":"130","author":"MM Hulshof","year":"1994","unstructured":"Hulshof MM, Pavel S, Breedveld FC, Dijkmans BA, Vermeer BJ (1994) Oral calcitriol as a new therapeutic modality for generalized morphea. Arch Dermatol 130(10):1290\u20131293","journal-title":"Arch Dermatol"}],"container-title":["Rheumatology International"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-011-2150-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00296-011-2150-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-011-2150-1","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,16]],"date-time":"2019-06-16T12:51:37Z","timestamp":1560689497000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00296-011-2150-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,9,27]]},"references-count":30,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2012,10]]}},"alternative-id":["2150"],"URL":"https:\/\/doi.org\/10.1007\/s00296-011-2150-1","relation":{},"ISSN":["0172-8172","1437-160X"],"issn-type":[{"value":"0172-8172","type":"print"},{"value":"1437-160X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,9,27]]}}}